170 related articles for article (PubMed ID: 36418141)
1. Examining the pharmacological and psychological treatment of child and adolescent ADHD in Australia: Protocol for a retrospective cohort study using linked national registry data.
Sullivan DP; Payne L; Boulton KA; Silove N; Bellgrove MA; Sciberras E; Coghill DR; Guastella AJ; Middeldorp CM
BMJ Open; 2022 Nov; 12(11):e064920. PubMed ID: 36418141
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and treatment of mental, behavioral, and developmental disorders in children with co-occurring autism spectrum disorder and attention-deficit/hyperactivity disorder: A population-based study.
Casseus M; Kim WJ; Horton DB
Autism Res; 2023 Apr; 16(4):855-867. PubMed ID: 36644987
[TBL] [Abstract][Full Text] [Related]
3. Training inhibitory control in adolescents with elevated attention deficit hyperactivity disorder traits: a randomised controlled trial of the Alfi Virtual Reality programme.
McKay E; Kirk H; Coxon J; Courtney D; Bellgrove M; Arnatkeviciute A; Cornish K
BMJ Open; 2022 Sep; 12(9):e061626. PubMed ID: 36127121
[TBL] [Abstract][Full Text] [Related]
4. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
Pediatrics; 2002 May; 109(5):733-9. PubMed ID: 11986429
[TBL] [Abstract][Full Text] [Related]
5. Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other psychiatric disorders: a Danish register-based study.
Dalsgaard S; Nielsen HS; Simonsen M
J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):432-9. PubMed ID: 24015896
[TBL] [Abstract][Full Text] [Related]
6. A longitudinal study of risk and protective factors associated with successful transition to secondary school in youth with ADHD: prospective cohort study protocol.
Zendarski N; Sciberras E; Mensah F; Hiscock H
BMC Pediatr; 2016 Jan; 16():20. PubMed ID: 26822230
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children.
Rappley MD; Mullan PB; Alvarez FJ; Eneli IU; Wang J; Gardiner JC
Arch Pediatr Adolesc Med; 1999 Oct; 153(10):1039-45. PubMed ID: 10520611
[TBL] [Abstract][Full Text] [Related]
8. Behavioural sleep problems in children with attention-deficit/hyperactivity disorder (ADHD): protocol for a prospective cohort study.
Lycett K; Sciberras E; Mensah FK; Gulenc A; Hiscock H
BMJ Open; 2014 Feb; 4(2):e004070. PubMed ID: 24523423
[TBL] [Abstract][Full Text] [Related]
9. Does a brief, behavioural intervention, delivered by paediatricians or psychologists improve sleep problems for children with ADHD? Protocol for a cluster-randomised, translational trial.
Sciberras E; Mulraney M; Heussler H; Rinehart N; Schuster T; Gold L; Hayes N; Hiscock H
BMJ Open; 2017 Apr; 7(4):e014158. PubMed ID: 28377393
[TBL] [Abstract][Full Text] [Related]
10. Psychiatric comorbidity in children and adolescents with restless legs syndrome: a retrospective study.
Pullen SJ; Wall CA; Angstman ER; Munitz GE; Kotagal S
J Clin Sleep Med; 2011 Dec; 7(6):587-96. PubMed ID: 22171196
[TBL] [Abstract][Full Text] [Related]
11. Use of medication by young people with attention-deficit/hyperactivity disorder.
Sawyer MG; Rey JM; Graetz BW; Clark JJ; Baghurst PA
Med J Aust; 2002 Jul; 177(1):21-5. PubMed ID: 12088474
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder.
Frazier TW; Shattuck PT; Narendorf SC; Cooper BP; Wagner M; Spitznagel EL
J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):571-9. PubMed ID: 22166171
[TBL] [Abstract][Full Text] [Related]
13. Protocol investigating the clinical utility of an objective measure of attention, impulsivity and activity (QbTest) for optimising medication management in children and young people with ADHD 'QbTest Utility for Optimising Treatment in ADHD' (QUOTA): a feasibility randomised controlled trial.
Hall CL; James M; Brown S; Martin JL; Brown N; Selby K; Clarke J; Vijayan H; Guo B; Sayal K; Hollis C; Groom MJ
BMJ Open; 2018 Feb; 8(2):e021104. PubMed ID: 29453304
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system stimulants for secondary attention deficit-hyperactivity disorder after paediatric traumatic brain injury: a rationale and protocol for single patient (n-of-1) multiple cross-over trials.
Senior HE; McKinlay L; Nikles J; Schluter PJ; Carmont SA; Waugh MC; Epps A; Lloyd O; Mitchell GK
BMC Pediatr; 2013 May; 13():89. PubMed ID: 23710976
[TBL] [Abstract][Full Text] [Related]
15. Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder.
Chen CY; Gerhard T; Winterstein AG
J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):187-95. PubMed ID: 19364296
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.
Cortese S; Adamo N; Mohr-Jensen C; Hayes AJ; Bhatti S; Carucci S; Del Giovane C; Atkinson LZ; Banaschewski T; Simonoff E; Zuddas A; Barbui C; Purgato M; Steinhausen HC; Shokraneh F; Xia J; Cipriani A; Coghill D;
BMJ Open; 2017 Jan; 7(1):e013967. PubMed ID: 28073796
[TBL] [Abstract][Full Text] [Related]
17. Early detection of Australian Aboriginal and Torres Strait Islander infants at high risk of adverse neurodevelopmental outcomes at 12 months corrected age: LEAP-CP prospective cohort study protocol.
Luke CR; Benfer K; Mick-Ramsamy L; Ware RS; Reid N; Bos AF; Bosanquet M; Boyd RN
BMJ Open; 2022 Jan; 12(1):e053646. PubMed ID: 34996793
[TBL] [Abstract][Full Text] [Related]
18. Medication Use in Youth With Autism and Attention-Deficit/Hyperactivity Disorder.
Rast JE; Anderson KA; Roux AM; Shattuck PT
Acad Pediatr; 2021 Mar; 21(2):272-279. PubMed ID: 32492579
[TBL] [Abstract][Full Text] [Related]
19. censusADHD Study: An Australian-wide medication-based recruitment study for Attention-Deficit/Hyperactivity Disorder.
Lind PA; Medland SE
Aust N Z J Psychiatry; 2023 Feb; 57(2):252-263. PubMed ID: 35360968
[TBL] [Abstract][Full Text] [Related]
20. Causal modelling of variation in clinical practice and long-term outcomes of ADHD using Norwegian registry data: the ADHD controversy project.
Mykletun A; Widding-Havneraas T; Chaulagain A; Lyhmann I; Bjelland I; Halmøy A; Elwert F; Butterworth P; Markussen S; Zachrisson HD; Rypdal K
BMJ Open; 2021 Jan; 11(1):e041698. PubMed ID: 33468528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
